Showing results (1661-1670 of 1,985) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|July 25, 2003
Neuropeptides: opportunities for drug discoveryTomas Hökfelt, Tamas Bartfai, Floyd Bloom
The Lancet. Neurology|July 25, 2003
Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugsPhilip N Patsalos, Emilio Perucca
The Lancet. Neurology|July 25, 2003
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disordersJack van Horssen, Pieter Wesseling, Lambert P W J van den Heuvel, et al.
The Lancet. Neurology|July 25, 2003
Memantine for the treatment of dementiaGordon K Wilcock
The Lancet. Neurology|August 28, 2003
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?Donato A Di Monte
The Lancet. Neurology|August 28, 2003
Spinal-cord MRI in multiple sclerosisGeert Lycklama, Alan Thompson, Massimo Filippi, et al.
The Lancet. Neurology|November 10, 2018
Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet. Neurology|November 13, 2018
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillationDavid J Seiffge, David J Werring, Maurizio Paciaroni, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
The Lancet. Neurology|October 19, 2016
The epidemiology of Parkinson's disease: risk factors and preventionAlberto Ascherio, Michael A Schwarzschild
Pageof 199